SAN DIEGO–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its third-quarter 2023 financial results. “We’re just a few months into our strategy of prioritizing reimbursed tests and growing revenue and are seeing faster progress than…Read More
DermTech Reports ThirdQuarter 2023 Financial Results
